SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors anticipate its optical interposer technology will be critical for next-generation AI data centers, fueled by strategic partnerships with industry giants like Luxshare and Foxconn that indirectly support hyperscalers like Meta and NVIDIA. The community is buzzing about POET's patented passive alignment process, which promises to revolutionize high-volume optical module manufacturing by enabling superior speed and energy efficiency over traditional copper. While eagerly awaiting official news, the market speculates on significant production orders ramping up by 2026, positioning POET as a potential leader in the rapidly expanding photonics sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after receiving positive FDA feedback, which significantly de-risks the regulatory pathway for sonelokimab in hidradenitis suppurativa by allowing reliance on existing trial data for BLA submission. This development has fueled widespread community speculation around potential acquisition bids from major pharmaceutical companies like Merck and Eli Lilly, intensifying discussions about the drug's long-term value and multi-indication potential.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is trending amid strong market interest in edge computing solutions for the defense sector, recently bolstered by a new pre-production order from a major U.S. defense contractor. The community is buzzing with anticipation for a much larger situational awareness system contract, viewing the company as a key player in a rapidly expanding industry with a low share float.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending with significant bullish momentum, fueled by strong community sentiment surrounding its role in the U.S. critical minerals and battery recycling sector. Investors are actively discussing the impact of rising lithium prices and the company's strategic positioning amidst government initiatives like the G7 summit on critical metals, anticipating future growth and potential project milestones. Many believe ABAT is poised for substantial appreciation as demand for domestic battery materials heats up.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as geopolitical tensions, notably around Venezuela, fuel community debate over potential market volatility, with many anticipating a significant spike amidst broader economic concerns like debt and an AI bubble. Despite overall market resilience, traders are sharply divided, actively discussing hedging strategies and drawing parallels to past market crashes, even as others caution against the ETF's inherent decay.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent high-grade silver drill results and anticipation for an updated resource estimate in Q1 2026, alongside continued significant investment from Eric Sprott. The community is actively debating the company's vast undeveloped potential amidst a global silver shortage and increasing industrial demand, while also considering the speculative nature and potential for future dilution. This places HYMC at the forefront of discussions regarding domestic precious metal resources in a tightening market.

Lulu's Fashion Lounge Holdings, Inc. engages in providing an online website for clothing. It offers retailing of women's clothing, shoes, and accessories. The company was founded in 1996 and is headquartered in Chico, CA.

Lulus Fashion Lounge Holdings Inc

Lulu's Fashion Lounge Holdings (LVLU) is generating significant buzz and volume after Friedland Enterprises disclosed a substantial stake, pushing for immediate governance reforms. The community is heavily discussing Friedland's strong belief that the stock is profoundly undervalued compared to its peers, citing a considerable valuation gap. This activist involvement and proposed operational improvements are driving widespread speculation about the company's potential for a major re-rating and sustained price movement.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

Biodesix (BDSX) is trending after releasing strong preliminary fourth quarter and full-year 2025 results, which reported significant revenue growth and reaffirmed Adjusted EBITDA positivity. This announcement has ignited massive trading volume and a sharp increase in share price, leading to community discussion around a potential short squeeze and significant upside, alongside concerns about future dilution risks.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor (TSM) is trending due to reports of an impending US-Taiwan trade agreement that could significantly expand its manufacturing presence in Arizona, alongside robust revenue growth and optimistic analyst upgrades. The community is actively discussing TSM's critical role as the backbone of the AI sector, driven by surging chip demand and its strategic advancements in packaging capacity amid evolving geopolitical considerations.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is seeing intense trading volume and significant volatility after releasing interim Phase 2 data for its cystic fibrosis therapy, ARCT-032, which showed encouraging mucus plug reduction but limited lung function improvement, leading to a sharp sell-off. The community is debating whether this represents an overreaction and a buying opportunity, given the drug's biological activity and potential for higher doses, or if it signals deeper concerns about the company's valuation and delayed regulatory submissions for other programs. Further discussions revolve around high short interest and a pending trade secret lawsuit, intensifying the stock's unpredictable movements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is it Time to Pay Attention to Value ETF Investing Again?

As geopolitical risks rise and volatility lingers, value investing stands out as an attractive strategy. Look at ETFs to simplify the implementation of the strategy.

The Zacks Analyst Blog Highlights VTV, JAVA, AVLV, IWS and VBR

Amid market volatility, value ETFs like VTV, JAVA, AVLV, IWS, and VBR offer stability, undervalued stock exposure, and potential long-term gains for investors.

Why Value ETFs Investing Could Be a Smart Move Right Now

Amid market uncertainty and overvalued equities, value investing with ETFs offer a safer, long-term path to steady returns.

Novo Nordisk A/S (NVO) shares slid 3% in the early premarket session on Monday as the Ozempic and Wegovy weight-loss drugmaker snagged a&nbsp;bearish recommendation from a Wall Street firm.&nbsp;Morgan Stanley analyst downgraded&nbsp;<a href="https://stocktwits.com/symbol/NVO">Novo Nordisk stock</a> to ‘Underweight’ from ‘Equal Weight’ and also reduced the price target for the stock to $47 from $59, the excerpts of the note published by The Fly showed. Morgan Stanley’s updated price target implies a nearly 13% downside from the stock’s Friday close.The stock was among the top five trending equity tickers on Stocktwits early Monday. Retail sentiment toward the stock, however, remained ‘extremely bullish’ (76/100), and the message volume on the stream was ‘high.’<figure class="image"><img style="aspect-ratio:619/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_29_at_5_23_05_AM_png_5def6a683f.webp" alt="Screenshot 2025-09-29 at 5.23.05 AM.png" width="619" height="53"><figcaption>NVO sentiment and message volume as of 5:20 a.m. ET, Sept. 29 | source: Stocktwits</figcaption></figure>Morgan Stanley attributed its negative thesis on the Danish company to its view that the weight loss prescription growth in the U.S. would slow down amid competitive pressures. According to the firm, this would drive downside revisions to the 2026 and 2027 consensus estimates for Novo Nordisk.&nbsp;Analysts at the firm said the lack of momentum in U.S. prescriptions for Wegovy, Ozempic and Rybelsus makes it cautious on the company's short-term growth profile. Additionally, the analyst noted that the lack of catalysts exacerbates the downside risk profile over the next six months.A New York Times report stated last week that the company was cutting jobs following the profit warning it issued in late July.&nbsp;Novo Nordisk stock has lost over 34% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-analyst-says-i-phone-s-worst-period-in-china-has-passed/chDMvs4R378">Apple Analyst Says ‘iPhone’s Worst Period In China Has Passed’ — The Xiaomi Data That Adds Strength To Bull Case For Cupertino</a>

In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. 

Why Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket Today

Morgan Stanley attributed its negative thesis on the Danish company to its view that the weight loss prescription growth in the U.S. would slow down amid competitive pressures.

Equity

Morgan Stanley attributed its negative thesis on the Danish company to its view that the weight loss prescription growth in the U.S. would slow down amid competitive pressures.



First Citizens BancShares Inc. stock rose 3% on Friday after the lender’s fourth-quarter earnings topped Wall Street estimates.On an adjusted basis, the company reported fourth-quarter (Q4) net earnings of $45.10 per share, compared with the market estimate of $39.11 per share, according to Koyfin data.Its net interest income (NII) declined by 10.6% year-over-year (YoY) to $1.71 billion, hurt by a fall in interest income on overnight investments due to a lower average balance and higher interest expense.The company said a rise in interest income on investment securities partly offset the decline.The Raleigh, North Carolina-based company said its net interest margin fell to 3.32% from 3.86% during the previous year.The lender said its non-interest income jumped 28.7% to $699 million, helped by higher rental income and gains from acquisition.The company, which had acquired the troubled lender Silicon Valley Bank in 2023, said its period-end loans and leases rose 5.2% to $140.22 billion while deposits rose 6.4%.Its provision for credit losses fell 37.8% to $155 million compared to last year.<a href="https://stocktwits.com/symbol/FCNCA">First Citizens BancShares</a> also forecasted 2025 net interest income between $6.6 billion and $7 billion.Retail sentiment on Stocktwits jumped to ‘extremely bullish’ (92/100) territory from ‘neutral’(47/100) a day ago and hit a year-high, while retail chatter soared to ‘extremely high.’<figure class="image"><img style="aspect-ratio:884/207;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/FCNCA_Jan_24_427bd90766.JPG" alt="FCNCA-Jan 24.JPG" width="884" height="207"><figcaption>FCNCA’s Sentiment Meter and Message Volume as of 11:56 a.m. ET on Jan. 24, 2025 | Source: Stocktwits</figcaption></figure>User comments were largely bullish on the stock.<stembedurl>https://stocktwits.com/Torontinoo_Banana_Genius/message/601324360</stembedurl>Last week, Wall Street’s major banks, including JP Morgan &amp; Chase, Citigroup, Wells Fargo, and Goldman Sachs, had all topped profit estimates.Over the past year, the stock has gained 62%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/american-express-stock-drops-on-q4-earnings-miss-but-retail-sentiment-hits-year-high/chbQ1aWRoi">American Express Stock Drops On Q4 Earnings Miss, But Retail Sentiment Hits Year High</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Charlotte, North Carolina, South Tryon Street, First Citizens Bank branch. (Photo by: Jeffrey Greenberg/Universal Images Group via Getty Images)

First Citizens BancShares Stock Gains After Upbeat Q4 Profit, Retail’s Jubilant

On an adjusted basis, the company reported fourth-quarter net earnings of $45.10 per share, compared with the market estimate of $39.11 per share, according to Koyfin data.

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

JAVA
JPMorgan Active Value ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest JAVA News

JAVAJPMorgan Active Value ETF